CD47 and periodontal disorder: Moreover, GV1001 was found to block lipid deposition associated with Pg-induced periodontal disease, potentially by reducing vascular inflammation, inhibiting the conversion of arterial endothelial cells to mesenchymal cells (EndMT), suppressing the expression of CD47 from arterial smooth muscle cells, and inhibiting foam cell formation.